Pharmacogenomic Testing for Hypertension, Hyperlipidemia, Hyperglycemia and Hyperuricemia Disease Medications, by detecting and analyzing the polymorphism of 57 genes related to 70 commonly used drugs for hypertension, hyperlipidemia, hyperglycemia and hyperuricemia, helps clinical drug use beyond the traditional framework of trial, observation and adjustment, guiding individualized medication in clinical practice, improving drug efficacy, helps determine appropriate dosage and reduces adverse drug reactions.
High efficiency and accuracy
Authoritative guidance
Convenient operation
Patients taking hypertension, hyperlipidemia, hyperglycemia and hyperuricemia drugs for the first time.
Patients taking multiple medications simultaneously or for a long time.
Patients who have an unsatisfactory response to a certain drug.
Patients who have had adverse drug reactions themselves or among their family members.
Certain groups (those with impaired liver or kidney function, the elderly, children, etc.).
People who attach importance to safe medication.
Individualized precision medicine
Provide reference for clinical rational drug use
Improve drug efficacy
Reduce adverse drug reactions
Informed consent
Sample collection
Nucleic acid extraction
Library preparation
Next generation sequencing
Data analysis
Reporting
7 to 10 working days after receiving qualified samples.